Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.
复制标题
DOI:
10.1038/cdd.2013.124
复制
发表时间:
2014-01
影响因子:
12.4
通讯作者:
中科院分区:
文献类型:
--
作者:
Clinical oncology heavily relies on the use of radiotherapy, which often leads to merely transient responses that are followed by local or distant relapse. The molecular mechanisms explaining radioresistance are largely elusive. Here, we identified a dual role of autophagy in the response of cancer cells to ionizing radiation. On one hand, we observed that the depletion of essential autophagy-relevant gene products, such as ATG5 and Beclin 1, increased the sensitivity of human or mouse cancer cell lines to irradiation, both in vitro (where autophagy inhibition increased radiation-induced cell death and decreased clonogenic survival) and in vivo, after transplantation of the cell lines into immunodeficient mice (where autophagy inhibition potentiated the tumour growth-inhibitory effect of radiotherapy). On the other hand, when tumour proficient or deficient for autophagy were implanted in immunocompetent mice, it turned out that defective autophagy reduced the efficacy of radiotherapy. Indeed, radiotherapy elicited an anti-cancer immune response that was dependent on autophagy-induced ATP release from stressed or dying tumour cells and was characterized by dense lymphocyte infiltration of the tumour bed. Intratumoural injection of an ecto-ATPase inhibitor restored the immune infiltration of autophagy-deficient tumours post radiotherapy and improved the growth-inhibitory effect of ionizing irradiation. Altogether, our results reveal that beyond its cytoprotective function, autophagy confers immunogenic properties to tumours, hence amplifying the efficacy of radiotherapy in an immunocompetent context. This has far-reaching implications for the development of pharmacological radiosensitizers.
登录
查看更多内容
影响因子:
11.2
作者:
Apel, Anja;Herr, Ingrid;Mayer, Andreas
通讯作者:
Mayer, Andreas
影响因子:
64.8
作者:
通讯作者:
--
DOI:
10.1158/1078-0432.ccr-09-0589
发表时间:
2009-10-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Kim KW;Moretti L;Mitchell LR;Jung DK;Lu B
通讯作者:
Lu B
影响因子:
64.5
作者:
Mathew R;Karp CM;Beaudoin B;Vuong N;Chen G;Chen HY;Bray K;Reddy A;Bhanot G;Gelinas C;Dipaola RS;Karantza-Wadsworth V;White E
通讯作者:
White E
影响因子:
2.6
作者:
Chen, Y. S.;Song, H. X.;Fu, T.
通讯作者:
Fu, T.